Chris Roberts
Finance Director
Chris Roberts is Group Finance Director with responsibility for the finance function across the Group.
Chris is a Chartered Certified Accountant. He was previously chief executive of The eVestment Company plc (now Evolution Group Plc) until it acquired Christows Group Limited in November 2000, remaining as group managing director of its private equity division until March 2001.
Chris has been a director of a number of publicly quoted businesses over the last ten years, including companies in fashion, telecoms, software and retail.
Bernard Leaver
Non-Executive Director
Bernard Leaver, 62, has over 30 years of experience in the financial services industry. From 1988-2002 he was a Managing Director at Lehman Brothers, where he was responsible for UK and European equities, and founded the European broker dealer and connectivity business. He has previously held non-executive directorships at Tullett Prebon and Collins Stewart Tullet.
James Noble
Chairman
James Noble is Chairman and member of the Remuneration Committee.
James Noble, 49, is currently Chief Executive Officer of Adaptimmune Limited and Immunocore Limited, two private biotechnology companies focused on T Cell Receptor technology. He is also on the Boards of Evolve Capital plc, Curagen Corporation, a NASDAQ listed company, Axellis Limited (a private company) and is Deputy Chairman of GW Pharmaceuticals, an AIM listed company. As an Executive, James Noble was formerly the CFO of British Biotech plc. Prior to that, he was a Director at Kleinwort Benson Limited after qualifying as an accountant at Price Waterhouse in 1983. He graduated from Oxford in 1980.
David Snow
Non-Executive Director
David Snow is a Non-Executive Director and member of the Remuneration Committee.
David began his career at Cayzer Limited, the merchant bank, in 1979 before joining the Harlow Butler Group in 1981 where he worked until 1999, latterly as Chief Executive of Harlow Butler UK Limited. In this role, as well as being responsible for over 500 brokers and more than 100 back office staff, he helped prepare Garban for its successful stock market flotation in 1998. Garban subsequently merged with ICAP in 1999. Since then David has focused on running and being involved in a number of private business and property ventures.